An understanding of mechanisms regulating gene expression in neurons is central to the understanding of neuronal development and function and to the analysis of disease processes as they affect neurons. Of particular interest are those genes which are unique to neurons or whose expression distinguishes neurons from other kinds of cells. The long-term objective of this research program is to elucidate through the techniques of molecular genetics those basic features of the DNA sequence and organization of neuronal genes which regulate and limit their expression to neurons. As a first step, the mechanisms controlling the expression of genes for the neurofilament will be investigated. Three genes specify proteins which comprise neurofilaments. These genes are active at high levels in neurons and are completely inactive in all other cell types in the body. The activities of these genes are discoordinately controlled during embryonic development but change coordinately when axons are damaged. The molecular mechanisms responsible for the control of these genes are expected to be complex and to involve the interaction of protein factors with specific regulatory sequences within the DNA of the genes. This project will use recombinant DNA clones and DNA sequence information already available to identify those regulatory sequences, and to search for postulated protein regulatory factors which bind to the DNA. To do this we propose to locate the major block of enhancer elements of the NF (M) and NF (H) genes and establish their 3' and 5' boundaries. We will demonstrate that these sequences are sufficient to specify neuron specific gene expression by investigating the expression in transgenic mice of hybrid genes containing these enhancer elements linked to simple reporter genes. Next we propose to identify component sequence motifs within the enhancer that are important for expression during differentiation of embryonal carcinoma cells to neuron-like cells or for neuron specific expression in transgenic mice. Ultimately, we will characterize the proteins that bind to these component motifs and obtain cDNA clones of them. Accumulations of neurofilaments or neurofilament-like proteins occur in a number of human disorders of the nervous system, including Alzheimer's and Parkinson's disease. The information obtained during this study on neurofilament gene regulation will constitute fundamental information for analyzing the molecular basis of pathological neurofilamentous changes in human.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005138-06
Application #
3813962
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Ki?emet-Piska?, Spomenka; Babi? Leko, Mirjana; Blažekovi?, Antonela et al. (2018) Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neurosci Ther 24:734-740
Soleimani, Laili; Ravona-Springer, Ramit; Heymann, Anthony et al. (2018) Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes. Int Psychogeriatr :1-5
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Audrain, Mickael; Haure-Mirande, Jean-Vianney; Wang, Minghui et al. (2018) Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry :
Boban, Mirta; Babi? Leko, Mirjana; Miški?, Terezija et al. (2018) Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species. J Neurosci Methods :
Zhu, Carolyn W; Grossman, Hillel; Neugroschl, Judith et al. (2018) A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study. Alzheimers Dement (N Y) 4:609-616
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Silverman, Jeremy M; Schmeidler, James (2018) Outcome age-based prediction of successful cognitive aging by total cholesterol. Alzheimers Dement 14:952-960

Showing the most recent 10 out of 555 publications